Loading...
Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide
BACKGROUND: Having performed analytical validation studies, we are now assessing the clinical utility of the upgraded automated Bone Scan Index (BSI) in metastatic castration-resistant prostate cancer (mCRPC). In the present study, we retrospectively evaluated the discriminatory strength of the auto...
Na minha lista:
| Udgivet i: | EJNMMI Res |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4785173/ https://ncbi.nlm.nih.gov/pubmed/26960325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13550-016-0173-z |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|